6-month consequences of COVID-19 in patients discharged from hospital: a cohort study | Lancet, The | 2021 | 1.3K |
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study | Lancet, The | 2021 | 149 |
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study | Lancet Respiratory Medicine,the | 2021 | 127 |
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study | Lancet, The | 2021 | 103 |
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline | European Respiratory Journal | 2021 | 76 |
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data | The Lancet Digital Health | 2021 | 58 |
Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis | International Journal of Cancer | 2021 | 58 |
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity | Clinical Microbiology and Infection | 2021 | 54 |
International Classification of Retinopathy of Prematurity, Third Edition | Ophthalmology | 2021 | 44 |
Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up | European Respiratory Journal | 2021 | 43 |
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms | Pharmacology & Therapeutics | 2021 | 39 |
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study | American Journal of Respiratory and Critical Care Medicine | 2021 | 38 |
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation | Cellular and Molecular Life Sciences | 2021 | 35 |
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study | Emerging Microbes and Infections | 2021 | 32 |
Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus | Annals of the Rheumatic Diseases | 2021 | 31 |
Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes | European Respiratory Journal | 2021 | 28 |
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia | Alzheimer's Research and Therapy | 2021 | 28 |
Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study | Journal of Bone and Mineral Research | 2021 | 25 |
Appropriateness of antibiotic prescriptions in ambulatory care in China: a nationwide descriptive database study | Lancet Infectious Diseases, The | 2021 | 24 |
Lung Myofibroblasts Promote Macrophage Profibrotic Activity through Lactate-induced Histone Lactylation | American Journal of Respiratory Cell and Molecular Biology | 2021 | 24 |
Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial | Clinical Infectious Diseases | 2021 | 24 |
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups | Nature Communications | 2021 | 21 |
Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice | Journal of Microbiology, Immunology and Infection | 2021 | 20 |
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19 | Clinical Microbiology and Infection | 2021 | 19 |
The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis | Clinical Infectious Diseases | 2021 | 19 |